Hypocalcemia was a common clinical and laboratory problem observed in our neonates. Late diagnosis causes complications such as cardiopulmonary dysfunction, hypocalcemic seizure and tetany, which increase neonatal morbidity and mortality (
8,
9). The aim of the present study was to determine the frequency of early and late hypocalcemia in hospitalized neonates and assess its associated factors. This report shows the importance of the evaluation, early detection and treatment of hypocalcemia in neonates to prevent subsequent serious complications.
Early hypocalcemia was more frequent than late hypocalcemia in our population (63% vs. 37%). Based on its etiology this frequency may diminish dramatically by some efforts; for instance sooner diagnosis and treatment of mothers with greater risk of diabetes, anticonvulsant drug and hyperparathyroidism may help physicians prevent neonatal early hypocalcemia. Consistent with our results Jain et al. confirmed that late neonatal hypocalcemia is rare as compared to early hypocalcemia (
3).
We found that early and late hypocalcemia were more common in neonates with one minute Apgar score of five or less. Birth asphyxia plays a critical role in neonatal calcium homeostasis. Neonatal asphyxia causes hypocalcemia by effects on calcium absorption, phosphorous concentration, calcitonin, parathormon status and infants’ oral intake (
10). In accordance to our results, Jain et al. confirmed that infants with perinatal asphyxia had lower serum Calcium (
3).
Based on our results, early or late hypocalcemia were more frequent in premature infants. Premature termination of trans-placental supply, exaggeration of the postnatal drop to hypocalcemic level, increased calcitonin and decrease target organ responsiveness to parathyroid hormone are considered as associated factors. A high percentage of hypocalcemia was detected in premature infants from 28 to 32 gestational weeks (
3).
Mothers’ diabetes also influenced the frequency of hypocalcemia in our hospitalized subjects; this may due to higher calcium demand by the macrosomic fetus or maternal fetal hypomagnesemia resulting hypoparathyroidism and hypocalcemia. Alam et al. showed high frequency of complications such as hypoglycemia and hypocalcemia in neonates of mothers with diabetes (
11). In one study, hypocalcemia was observed in 17% of neonates whose mothers had gestational or pregestational diabetes (
12).
We also found that seizure was the most common symptom in early and late hypocalcemia and this finding was consistent with other previous studies (
13,
14). Cakir et al. (
9) also reported that neonatal hypocalcemia may present different symptoms such as hypotonia, poor feeding, stridor, and jitteriness, yet the most alarming symptom was the seizure activity.
Finally we found that amongst the 18 neonates with doubt in hypomagnesemia, seven cases (38.8%) had hypocalcemia and hypomagnesemia, simultaneously. A previous investigation has indicated that neonatal hypomagnesemia can induce hypoparathyroidism resulting hypocalcemia (
3). Visudhiphan et al. also showed hypomagnesemia with secondary hypocalcemia in their study (
15).
Our study had some limitations. Firstly, our sample size was small thus we could not evaluate more maternal complications. We also did not consider other factors such as Vitamin D status or maternal calcium level as other associated factors and we suggest that these variables should be considered in future studies.
As hypocalcemia in our population was more frequent, calcium supplemented food should prevent hypocalcemia complications in high-risk neonates.